Maine § 5 §20047 Records

Maine Statutes

§ 5 §20047 — Records

Maine § 5 §20047

Title 5ADMINISTRATIVE PROCEDURES AND SERVICES

Part 25SUBSTANCE USE DISORDER PREVENTION, TREATMENT AND RECOVERY

This text of Maine § 5 §20047 (Records) is published on Counsel Stack Legal Research, covering Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Me. Rev. Stat. tit. 5, § 5 §20047 (2026).

Text

1.Registration and records. Registration and other records of treatment facilities must remain confidential and are privileged to the patient.

2.Information for research. Notwithstanding subsection 1, the commissioner may make available information from patients' records for purposes of research into the causes and treatment of substance use disorder. Information under this subsection may not be published in a way that discloses patients' names or other identifying information.

3.(TEXT EFFECTIVE ON CONTINGENCY: See PL 2017, c. 243, §5) Medical emergency; methadone. Notwithstanding subsection 1, records relating to methadone treatment of a patient for the treatment of opioid dependency that have been entered into the Controlled Substances Prescription Monitoring Program established under

Free access — add to your briefcase to read the full text and ask questions with AI

1.
Registration and records.
Registration and other records of treatment facilities must remain confidential and are privileged to the patient.
2.
Information for research.
Notwithstanding subsection 1, the commissioner may make available information from patients' records for purposes of research into the causes and treatment of substance use disorder. Information under this subsection may not be published in a way that discloses patients' names or other identifying information.
3.
(TEXT EFFECTIVE ON CONTINGENCY: See PL 2017, c. 243, §5) Medical emergency; methadone.
Notwithstanding subsection 1, records relating to methadone treatment of a patient for the treatment of opioid dependency that have been entered into the Controlled Substances Prescription Monitoring Program established under Title 22, section 7248 may be disclosed in an emergency setting only to the extent necessary to meet a bona fide medical emergency in which the patient's prior informed consent cannot be obtained and only to the health care professionals involved in treating the patient. Any disclosure of records pursuant to this subsection must be documented as described in Title 22, section 7250, subsection 7.

Legislative History

PL 1989, c. 934, §A3 (NEW). PL 2011, c. 657, Pt. AA, §40 (AMD). PL 2017, c. 243, §1 (AMD). PL 2017, c. 243, §5 (AFF). PL 2017, c. 407, Pt. A, §39 (AMD).